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Background
Alcaftadine is a novel drug available in eye drops to
treat allergic conjunctivitis.
Methods
This is a case report.
Results
A 32-year-old Brazilian woman presented with chronic
pruritic eyes for three years and recurrent episodes of
eyelid inflammation during the last six months in an
ophthalmology practice. The clinical finds were conjunc-
tival hyperemia and edema of the eyelids. The hypothesis
of perennial allergic conjunctivitis was done and the use
of alcaftadine eye drops once a day was prescribed. She
returned after two weeks and the worsening of the symp-
toms was related. She was advised to visit an allergist and
to stop the use of alcaftadine. At that time she had
edema and erythema of both eyelids. Allergic contact ble-
pharoconjunctivitis was suspected and standardized patch
test as well as products she was using on the face, on the
hair and over the eyes were tested. Alcaftadine (+++48h/
+++96h), hidroquinone (+++48h/+++96h), fragrance mix
(++48h/+96h), triethanolamine (++48h/+96h), shampoo
(+++48h/+++96h) were positive. Benzalkonium chloride,
a preservative found in alcaftadine, was negative. SPT to
grass pollen and house dust mites were positive. Avoid-
ance of alcaftadine and shampoo, use of preservative free
eye lubricants, nasal corticosteroids and environmental
control had completely cleared the symptoms.
Conclusions
Ocular allergies encompass a number of inflammatory
diseases in the ocular surface which have different
hypersensitivity mechanisms and occur in 20% of
population. The different syndromes can coexist and it
is very important to be aware about the possibility of
drug sensitization in these cases. Furthermore, a multi-
disciplinary approach by allergists and ophthalmologists
is required to fully understand these patients.
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